RFA
NVCR icon

Reilly Financial Advisors’s NovoCure NVCR Stock Holding History

Reilly Financial Advisors’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$2K Buy
+30
New +$3.01K ﹤0.01% 1002

Other funds holding NVCR

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Reilly Financial Advisors's NVCR Position: Q4 2021 in Review

Reilly Financial Advisors opened a new position in NovoCure (NVCR) in Q4 2021: 30 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #1002 among its holdings.

312 funds tracked by Wall St. Rank hold NVCR as of Q4 2021.

  • Reilly Financial Advisors held 30 shares of NovoCure worth $2K as of Q4 2021.
  • NovoCure was a new Reilly Financial Advisors position in Q4 2021.
  • NovoCure made up ﹤0.01% of Reilly Financial Advisors's portfolio in Q4 2021, its #1002 holding.
  • 312 funds tracked by Wall St. Rank held NovoCure as of Q4 2021.

Based on Reilly Financial Advisors's 13F filing for Q4 2021, filed 25 Jan 2022.